Biocept, Inc. (BIOC): Price and Financial Metrics

Biocept, Inc. (BIOC): $3.86

-0.19 (-4.69%)

POWR Rating

Component Grades














  • Growth is the dimension where BIOC ranks best; there it ranks ahead of 94.69% of US stocks.
  • BIOC's strongest trending metric is Momentum; it's been moving down over the last 51 weeks.
  • BIOC's current lowest rank is in the Stability metric (where it is better than 1.27% of US stocks).

BIOC Stock Summary

  • BIOC has a higher market value than merely 8.55% of US stocks; more precisely, its current market capitalization is $59,627,980.
  • With a year-over-year growth in debt of 319.82%, Biocept Inc's debt growth rate surpasses 96.76% of about US stocks.
  • Revenue growth over the past 12 months for Biocept Inc comes in at 867.07%, a number that bests 98.87% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Biocept Inc are EVFM, AQB, NISN, XERS, and MARK.
  • Visit BIOC's SEC page to see the company's official filings. To visit the company's web site, go to

BIOC Valuation Summary

  • BIOC's EV/EBIT ratio is -24.3; this is 182.94% lower than that of the median Healthcare stock.
  • Over the past 92 months, BIOC's price/sales ratio has gone down 304.2.
  • BIOC's price/sales ratio has moved down 304.2 over the prior 92 months.

Below are key valuation metrics over time for BIOC.

Stock Date P/S P/B P/E EV/EBIT
BIOC 2021-08-31 1.0 1.8 -24.2 -24.3
BIOC 2021-08-30 0.9 1.8 -23.6 -23.7
BIOC 2021-08-27 0.9 1.8 -23.5 -23.5
BIOC 2021-08-26 0.9 1.7 -23.2 -23.2
BIOC 2021-08-25 0.9 1.8 -23.5 -23.5
BIOC 2021-08-24 0.9 1.7 -22.6 -22.5

BIOC Growth Metrics

  • Its 2 year revenue growth rate is now at 41.94%.
  • The 3 year revenue growth rate now stands at 408.99%.
  • Its year over year revenue growth rate is now at 635.54%.
Over the past 49 months, BIOC's revenue has gone up $49,599,845.

The table below shows BIOC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 54.90074 -5.005328 -2.20445
2021-03-31 43.77104 -13.66441 -6.866274
2020-12-31 27.4614 -19.7871 -17.80968
2020-09-30 10.73391 -24.15599 -25.44706
2020-06-30 5.677024 -23.04972 -26.26049
2020-03-31 5.950876 -23.08061 -27.5872

BIOC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BIOC has a Quality Grade of D, ranking ahead of 16.08% of graded US stocks.
  • BIOC's asset turnover comes in at 1.212 -- ranking 13th of 81 Healthcare stocks.
  • LH, TDOC, and SSY are the stocks whose asset turnover ratios are most correlated with BIOC.

The table below shows BIOC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.212 0.411 -0.069
2021-03-31 1.070 0.374 -0.312
2020-12-31 0.768 0.223 -1.341
2020-09-30 0.379 -0.323 -4.029
2020-06-30 0.239 -0.968 -4.770
2020-03-31 0.290 -0.903 -5.429

BIOC Price Target

For more insight on analysts targets of BIOC, see our BIOC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $12.00 Average Broker Recommendation 1.5 (Moderate Buy)

BIOC Stock Price Chart Interactive Chart >

Price chart for BIOC

BIOC Price/Volume Stats

Current price $3.86 52-week high $8.38
Prev. close $4.05 52-week low $3.26
Day low $3.86 Volume 213,500
Day high $4.07 Avg. volume 662,323
50-day MA $3.83 Dividend yield N/A
200-day MA $4.75 Market Cap 56.83M

BIOC Latest News Stream

Event/Time News Detail
Loading, please wait...

BIOC Latest Social Stream

Loading social stream, please wait...

View Full BIOC Social Stream

Latest BIOC News From Around the Web

Below are the latest news stories about Biocept Inc that investors may wish to consider to help them evaluate BIOC as an investment opportunity.

Biocept to Present at the LD Micro Main Event on October 13

SAN DIEGO, October 06, 2021--Biocept to present at LD Micro Main Event

Yahoo | October 6, 2021

Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Battling cancer is often a long journey—and one that becomes even more challenging for the large number of patients who find that the cancer may have spread to their brain or spinal cord. Between 10% and 30% of cancer patients, and a much higher percentage of late-stage cancer patients will develop brain or spinal cord metastasis. There are an

Yahoo | September 29, 2021

Liquid Biopsy Global Market Report 2021: COVID-19 Growth And Change To 2030

Major players in the liquid biopsy market are QIAGEN N. V. , Roche Diagnostics, Bio-Rad Laboratories Inc. , Myriad Genetics, Inc. , Guardant Health Inc. , Thermo Fisher Scientific, Guardant Health, Menarini Silicon Biosystems, Biocept, Inc. Major players in the liquid biopsy market are QIAGEN N. V. , Roche Diagnostics, Bio-Rad Laboratories Inc. , Myriad Genetics, Inc. , Guardant Health Inc. , Thermo Fisher Scientific, Guardant Health, Menarini Silicon Biosystems, Biocept, Inc.

Intrado Digital Media | September 28, 2021

Biocept Implements COVID-19 Testing Program at Select California Community Colleges, Supporting Testing Needs for Students and Staff Amid Pandemic

SAN DIEGO--(BUSINESS WIRE)--Biocept provides on-campus COVID-19 testing to over 30 California community colleges, as students and staff return to in-person learning.

Business Wire | September 22, 2021

Biocept Invites You to Join Us at the Benzinga Healthcare Small Cap Conference

Detroit, Michigan--(Newsfile Corp. - September 22, 2021) - Biocept (NASDAQ: BIOC) will be presenting at the Benzinga Healthcare Small Cap Conference being held September 29-30, 2021. We invite our

FinanzNachrichten | September 22, 2021

Read More 'BIOC' Stories Here

BIOC Price Returns

1-mo -3.74%
3-mo 0.26%
6-mo -4.22%
1-year -17.87%
3-year -83.50%
5-year -98.57%
YTD -13.06%
2020 55.24%
2019 -66.74%
2018 -95.85%
2017 -10.39%
2016 -81.40%

Continue Researching BIOC

Want to see what other sources are saying about Biocept Inc's financials and stock price? Try the links below:

Biocept Inc (BIOC) Stock Price | Nasdaq
Biocept Inc (BIOC) Stock Quote, History and News - Yahoo Finance
Biocept Inc (BIOC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8066 seconds.